Sylvain Carras

A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma

Emmanuel Bachy, Steven Le Gouill, Roberta Di Blasi et al. · Nature Medicine · 2022 · 383 citations · Full text

Medicine, Hematology, Oncology +15

Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells

Pierre Sesques, Jérémie Tordo, Emmanuelle Ferrant et al. · Clinical Nuclear Medicine · 2021 · 81 citations

Medicine, Oncology, Hematologic Oncology +15

Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry

Jean Lemoine, Emmanuel Bachy, Guillaume Cartron et al. · Blood Advances · 2023 · 77 citations · Full text

Medicine, Immunology, Oncology +13

Primary cardiac lymphoma: diagnosis, treatment and outcome in a modern series

Sylvain Carras, Françoise Berger, Lara Chalabreysse et al. · Hematological Oncology · 2016 · 70 citations

Medicine, Cardiology, Oncology +11

First‐line treatment of double‐hit and triple‐hit lymphomas: Survival and tolerance data from a retrospective multicenter French study

Marie‐Charlotte Laude, Laure Lebras, Pierre Sesques et al. · American Journal of Hematology · 2020 · 50 citations · Full text

Medicine, Oncology, Chemotherapy +14